Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

Why Did Star Combo Pharma's (ASX:S66) FY26 Profit Fall While Cash Stayed Near $18 Million?

Revenue from ordinary activities fell $4,238,498 to $23,573,050, a decline of 15% against FY25. Profit before tax attributable to owners was $528,472, compared with $5,312,588, and profit after tax attributable to owners was $1,176,626, down $4,075,716 from $5,252,342. Net tangibleAssetsper ordinary security were 0.28 …

Sonal Goyal | 16 October 2026

How Did Sigma Healthcare (ASX:SIG) Report 20.6% Normalised EBIT Growth in Its First Full Year With Chemist Warehouse?

Revenue of $10.8 billion was up 15.5%. Normalised EBIT of $1,090.0 million was up 20.6%, with the margin rising to 10.1% from 9.6%, and normalised NPAT of $732.3 million was up 22.3%. Net debt declined to $663.2 million, or 0.57 times normalised EBITDA, and …

Sonal Goyal | 16 October 2026

What Does Ocean Sciences' (ASX:OSS) Finalised Development Plan for the Takalar Seaweed Centre Involve?

The plan follows the recently announced extension of the approximately 3.4 hectare site lease until April 2031, which the company says gives medium-term certainty to develop and operate the Centre. At the end of the extended term, the company may seek a further five-year …

Sonal Goyal | 16 October 2026

How Did Peak Processing (ASX:PKP) Reach Its First Positive EBITDA Quarter in the June 2026 Period?

Revenue of about A$4.4 million was up about 40% on Q3 FY26's A$3.2 million and was the highest quarterly revenue of FY26. Group EBITDA was A$710,000, aMarginof about 16%, against a loss of about A$0.3 million in Q3. EBITDA is stated on a consolidated …

Sonal Goyal | 16 October 2026

How Did Terragen Holdings (ASX:TGH) Report FY26 Revenue, Losses and a Larger Cash Balance?

Revenue from ordinary operations was $1,432,082, down 11.3% from $1,615,253. The loss after tax attributable to members was $3,751,367, up 0.7% from $3,723,830, and the net loss attributable to members was $3,757,196. Net tangible assets per ordinary security were 1.06 cents, against 1.13 cents. …

Sonal Goyal | 16 October 2026

How Did Oakridge International (ASX:OAK) Return to Profit in FY26 With 42% Higher Revenue?

Revenue from ordinary activities was $3,446,008, up 42% or $1,012,668 on the prior year, which the company attributes mainly to increased sales from business development activities. Profit attributable to owners was $109,171, up 185%, reversing a loss of $128,795. Net tangible assets per ordinary …

Sonal Goyal | 16 October 2026

What Did the Five-Patient Remplir Prostatectomy Case Series Show for Orthocell (ASX:OCC)?

The series included five patients aged 57 to 69, most with other conditions such as diabetes, high blood pressure or obesity, and some with urinary symptoms or erectile dysfunction before surgery. All had cancer that had grown beyond the outer edge of the prostate, …

Sonal Goyal | 16 October 2026

What Does the FDA 510(k) Lodgement for InVue Mean for Optiscan Imaging's (ASX:OIL) US Plans?

Optiscan unveiled InVue in June 2024 as a next-generation microscopic imaging device for precision surgery. It is designed to give surgeons cellular-level imaging in the operating environment, so tissue can be assessed in real time while the patient remains in theatre. The company sees …

Sonal Goyal | 16 October 2026

What Does OncoSil Medical's (ASX:OSL) Role in the PALACROS European Programme Involve?

PALACROS is described as a European research initiative supported by the Horizon Europe programme and the EU Mission on Cancer. It brings together hospitals, researchers, patient organisations and industry partners to investigate innovative treatment approaches and improve care pathways for LAPC, with aims including …

Sonal Goyal | 16 October 2026

How Does Osteopore (ASX:OSX) Plan to Enter the Thai Orthopaedic Market After Securing Market Access?

Osteopore has also secured itsSupplychain and logistics network into Thailand through aPartnershipwith DCH Auriga, an Asia-based integrated market management provider specialising in healthcare. Auriga will be Osteopore's market authorisation holder,Importits devices into Thailand and supply hospitals and clinics as directed by Osteopore. Auriga operates …

Sonal Goyal | 16 October 2026
Support

Hi! How can we help you today?

Loading…